Biography
Professional experience of Dr Ružica Tomičić as a Research Associate at the Department of Biotechnology, Faculty of Technology, University of Novi Sad, Serbia, includes microbiological research in the field of medicine and food safety, as well as molecular biology. Research is focused on studying the virulence factors of pathogens, their identification and whole genome sequencing, antimicrobial activity of natural compounds (essential oils, plant extracts, phenols...) and disinfectants in the prevention and elimination of microbial biofilms. Studies also include investigating the application of natural compounds and probiotics in food in order to create functional products.
Research Interest
Microbiology, Biotechnology, Molecular Biology, Infectious Diseases, Food Safety.
Editor
Work Details
PhD
University of Novi Sad
Department of Biotechnology
Serbia
Contribution by Topic Area
Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
Research Articles
- Methodology of the Professional-Business Game for the Development of a Cadet Leader in Professional Training Courses (L-1B) of the Tactical Level of Military Education
- Synergistic Assessment of Supplementation of Ascorbic Acid and Massularia acuminata Extracts on Serum Electrolyte and Lipid Profile Indices of Dyslipidemia in Adult Wistar Rats Exposed to Aluminum Chloride Toxicity
- A Model of the Enforcement of Laws in Tramadol Drug Abusers
- Evaluating Digital Imaging Technologies for Anogenital Injury Documentation in Sexual Assault Cases
- Slip Resistance Evaluation of 10 Indoor Floor Surfaces
- Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis
Advertisement


